Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
Corbus Pharmaceuticals, a precision oncology company, today announced the appointment of Yong Ben, M.D., MBA, […]
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and […]
Aptar Appoints Julie Xing to its Board of Directors
Aptar Group, a global leader in drug delivery, consumer product dispensing and active material science […]
Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a […]
AlloVir Appoints Derek Adams, Ph.D., to Board of Directors
AlloVir, a late-clinical stage allogeneic T cell immunotherapy company, today announced the appointment of Derek […]
Halozyme Appoints Barbara Duncan to its Board of Directors
Halozyme Therapeutics today announced the appointment of Barbara Duncan to its Board of Directors. Ms. Duncan brings more […]
Poseida Therapeutics Announces Board Change
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines […]
Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors
Vesigen Therapeutics, a biotechnology company developing transformative therapeutics by engineering naturally existing vesicles, today announced […]
Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors
Kinnate Biopharma, a clinical-stage precision oncology company, has announced that its board of directors has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more